Thomas Catinazzo
Director of Finance/CFO at RELAY THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Network origin in Thomas Catinazzo first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Catinazzo via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| FORRESTER RESEARCH, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Masters Business Admin Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
| Universität Salzburg | College/University | Graduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| SCHRÖDINGER, INC. | Packaged Software | Corporate Officer/Principal | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Corporate Officer/Principal Chairman | |
Strategic Decisions Group
 Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Strategic Decisions Group provides consulting solutions. Its solutions include business strategy, portfolio management and allocation, decision and risk analytics, and organization and decision process design. The company was founded by Ronald A. Howard in 1981 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
The Sidney Kimmel Comprehensive Cancer Center
 The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer President | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | Chairman | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Quentis Therapeutics, Inc.
 Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
SB Investment Advisers (UK) Ltd.
 SB Investment Advisers (UK) Ltd. Investment ManagersFinance SB Investment Advisers (UK) Ltd. is a Private Equity firm, a subsidiary of SoftBank Group Corp. founded in 2016 by Masayoshi Son. SB Investment Advisers (UK) Ltd. is headquartered in London, UK. | Investment Managers | Private Equity Investor | |
Section 32 LLC
 Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Investment Managers | Private Equity Investor | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Consultant / Advisor | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Chief Executive Officer Founder | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
BigHat Biosciences, Inc.
 BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Analyst Private Equity Investor | |
| EQRX, INC. | Pharmaceuticals: Major | Director of Finance/CFO Founder | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
TenSixty Biosciences, Inc.
 TenSixty Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services TenSixty Biosciences, Inc. provides small molecule therapeutics discovery services. The company is based in Cambridge, MA. The CEO of the company is Daniel Montoro. | Miscellaneous Commercial Services | Director/Board Member | |
| DA32 LIFE SCIENCE TECH ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer | |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Sunbird Bio, Inc.
 Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 44 |
| Austria | 2 |
| Germany | 2 |
| France | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 7 |
| Technology Services | 3 |
Operational
| Director/Board Member | 118 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 37 |
| Chief Executive Officer | 22 |
| Founder | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Dipchand Nishar | 31 |
| Alexis Borisy | 25 |
| Linda Hill | 20 |
| Steven Kafka | 19 |
| Laura Shawver | 18 |
| Christoph S. Lengauer | 16 |
| Douglas Ingram | 14 |
| Mark Murcko | 14 |
| Jami Rubin | 12 |
| Markus Warmuth | 11 |
| Donald Bergstrom | 9 |
| Sanjiv Patel | 9 |
| Ben Wolf | 9 |
| Deborah Palestrant | 8 |
| Sekar Kathiresan | 8 |
- Stock Market
- Insiders
- Thomas Catinazzo
- Company connections